2023 Q2 Form 10-Q Financial Statement

#000165495423005964 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $17.60M $16.80M
YoY Change 46.76% 48.3%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $820.0K $903.0K
YoY Change -56.59% -44.12%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $3.828M $2.463M
YoY Change 494.41% 271.49%
% of Operating Profit
Other Income/Expense, Net $283.0K $211.0K
YoY Change 732.35% 441.03%
Pretax Income $6.180M $4.023M
YoY Change 53.62% 5566.2%
Income Tax $1.372M $851.0K
% Of Pretax Income 22.2% 21.15%
Net Earnings $4.808M $3.172M
YoY Change 49.46% -8.11%
Net Earnings / Revenue 27.32% 18.88%
Basic Earnings Per Share $0.88 $0.58
Diluted Earnings Per Share $0.85 $0.56
COMMON SHARES
Basic Shares Outstanding 5.637M shares 5.637M shares
Diluted Shares Outstanding 5.634B shares 5.656B shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $485.7M $484.8M
YoY Change -25.65% -32.36%
Cash & Equivalents $89.04M $83.02M
Short-Term Investments $396.7M $401.8M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $16.73M $18.19M
YoY Change 4.58% 16.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.612B $1.603B
YoY Change -3.9% -3.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.90M $14.44M
YoY Change 34.0% 21.13%
Accrued Expenses $5.100M $5.033M
YoY Change -15.6% -19.79%
Deferred Revenue
YoY Change
Short-Term Debt $93.20M $39.54M
YoY Change 150.9% 13.53%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $114.2M $59.00M
YoY Change 537.67% 224.32%
LONG-TERM LIABILITIES
Long-Term Debt $15.50M $15.46M
YoY Change 0.23% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $15.50M $15.46M
YoY Change 0.23% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $114.2M $59.00M
Total Long-Term Liabilities $15.50M $15.46M
Total Liabilities $1.499B $1.488B
YoY Change -4.17% -3.21%
SHAREHOLDERS EQUITY
Retained Earnings $104.3M $100.6M
YoY Change 12.47% 11.07%
Common Stock $51.81M $52.64M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $112.4M $114.8M
YoY Change
Total Liabilities & Shareholders Equity $1.612B $1.603B
YoY Change -3.9% -3.61%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $4.808M $3.172M
YoY Change 49.46% -8.11%
Depreciation, Depletion And Amortization $820.0K $903.0K
YoY Change -56.59% -44.12%
Cash From Operating Activities $4.840M $8.042M
YoY Change 183.37% 12.27%
INVESTING ACTIVITIES
Capital Expenditures $380.0K $566.0K
YoY Change -140.43% 274.83%
Acquisitions
YoY Change
Other Investing Activities -$6.240M $35.80M
YoY Change -94.24% -215.32%
Cash From Investing Activities -$6.640M $35.24M
YoY Change -93.92% -212.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.820M -$31.85M
YoY Change -70.09% -161.68%
NET CHANGE
Cash From Operating Activities 4.840M $8.042M
Cash From Investing Activities -6.640M $35.24M
Cash From Financing Activities 7.820M -$31.85M
Net Change In Cash 6.020M $11.43M
YoY Change -107.4% -58.62%
FREE CASH FLOW
Cash From Operating Activities $4.840M $8.042M
Capital Expenditures $380.0K $566.0K
Free Cash Flow $4.460M $7.476M
YoY Change 68.43% 6.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
10494000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1022114000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18205000 usd
CY2022Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
17703000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
9617000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1041254000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18194000 usd
CY2023Q1 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
17806000 usd
CY2022Q1 pebk Chargeoffs
Chargeoffs
-160000 usd
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
14436000 usd
CY2023Q1 pebk Accrued Interest Receivable And Other Assets
AccruedInterestReceivableAndOtherAssets
35275000 usd
CY2023Q1 us-gaap Assets
Assets
1602692000 usd
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
502702000 usd
CY2023Q1 pebk Interest Bearing Demand Mmda Savings
InterestBearingDemandMmdaSavings
742473000 usd
CY2023Q1 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
67595000 usd
CY2023Q1 us-gaap Deposits
Deposits
1413441000 usd
CY2023Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
39535000 usd
CY2023Q1 us-gaap Subordinated Debt
SubordinatedDebt
15464000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5033000 usd
CY2023Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
383000 usd
CY2022Q4 pebk Common Stock Held By Deferred Compensation Trust At Cost
CommonStockHeldByDeferredCompensationTrustAtCost
-2181000 usd
CY2023Q1 us-gaap Interest Income Securities Us Treasury And Other Us Government
InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment
2230000 usd
CY2022Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
111000 usd
CY2023Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
42921000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
52642000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
100565000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-38424000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
114783000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1602692000 usd
CY2023Q1 pebk Available For Sale Of Securities
AvailableForSaleOfSecurities
399148000 usd
CY2022Q4 pebk Available For Sale Of Securities
AvailableForSaleOfSecurities
445394000 usd
CY2023Q1 pebk Other Investment
OtherInvestment
2628000 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001093672
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 pebk Cash And Due From Banks Reserve
CashAndDueFromBanksReserve
0 usd
CY2022Q4 pebk Time
Time
250000000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5636830000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5637021000 shares
CY2022Q4 us-gaap Net Investment In Lease Nonaccrual No Allowance
NetInvestmentInLeaseNonaccrualNoAllowance
0 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-27205
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
PEOPLES BANCORP OF NORTH CAROLINA, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NC
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2132396
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
518 West C Street
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Newton
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
28658
CY2023Q1 dei City Area Code
CityAreaCode
828
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
464-5620
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5637021 shares
CY2023Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
40100000 usd
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
50061000 usd
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
21535000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83021000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71596000 usd
CY2022Q4 pebk Other Investment
OtherInvestment
2656000 usd
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
401776000 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
448050000 usd
CY2023Q1 us-gaap Inventory Real Estate Mortgage Loans Held In Inventory
InventoryRealEstateMortgageLoansHeldInInventory
417000 usd
CY2022Q4 us-gaap Inventory Real Estate Mortgage Loans Held In Inventory
InventoryRealEstateMortgageLoansHeldInInventory
211000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1050871000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1032608000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4949000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5116000 usd
CY2022Q4 pebk Accrued Interest Receivable And Other Assets
AccruedInterestReceivableAndOtherAssets
37932000 usd
CY2022Q4 us-gaap Assets
Assets
1620927000 usd
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
523088000 usd
CY2022Q4 pebk Interest Bearing Demand Mmda Savings
InterestBearingDemandMmdaSavings
814128000 usd
CY2022Q4 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
31001000 usd
CY2023Q1 us-gaap Time Deposits Less Than100000
TimeDepositsLessThan100000
100671000 usd
CY2022Q4 us-gaap Time Deposits Less Than100000
TimeDepositsLessThan100000
66998000 usd
CY2022Q4 us-gaap Deposits
Deposits
1435215000 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
47688000 usd
CY2022Q4 us-gaap Subordinated Debt
SubordinatedDebt
15464000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5185000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
12180000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1487909000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1515732000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
52636000 usd
CY2023Q1 pebk Common Stock Held By Deferred Compensation Trust At Cost
CommonStockHeldByDeferredCompensationTrustAtCost
-1837000 usd
CY2023Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
1837000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2181000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
100156000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47597000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
105195000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1620927000 usd
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
12883000 usd
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
9742000 usd
CY2022Q1 us-gaap Interest Income Securities Us Treasury And Other Us Government
InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment
505000 usd
CY2023Q1 us-gaap Interest Income Securities State And Municipal
InterestIncomeSecuritiesStateAndMunicipal
862000 usd
CY2022Q1 us-gaap Interest Income Securities State And Municipal
InterestIncomeSecuritiesStateAndMunicipal
943000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
443000 usd
CY2022Q1 us-gaap Other Income
OtherIncome
28000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
16801000 usd
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
11329000 usd
CY2023Q1 pebk Interest Bearing Demand Mmda Savings Deposits
InterestBearingDemandMmdaSavingsDeposits
1488000 usd
CY2022Q1 pebk Interest Bearing Demand Mmda Savings Deposits
InterestBearingDemandMmdaSavingsDeposits
403000 usd
CY2023Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
516000 usd
CY2022Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
146000 usd
CY2023Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
248000 usd
CY2022Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
75000 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
211000 usd
CY2022Q1 us-gaap Other Expenses
OtherExpenses
39000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2463000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
663000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
14338000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
10666000 usd
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
224000 usd
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
71000 usd
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
14114000 usd
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
10595000 usd
CY2023Q1 pebk Service Charges
ServiceCharges
1341000 usd
CY2022Q1 pebk Service Charges
ServiceCharges
1168000 usd
CY2023Q1 pebk Other Service Charges And Fees
OtherServiceChargesAndFees
182000 usd
CY2022Q1 pebk Other Service Charges And Fees
OtherServiceChargesAndFees
193000 usd
CY2023Q1 us-gaap Debt Securities Gain Loss
DebtSecuritiesGainLoss
-2488000 usd
CY2022Q1 us-gaap Debt Securities Gain Loss
DebtSecuritiesGainLoss
0 usd
CY2023Q1 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
93000 usd
CY2022Q1 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
200000 usd
CY2023Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
228000 usd
CY2022Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
240000 usd
CY2023Q1 us-gaap Property Management Fee Revenue
PropertyManagementFeeRevenue
2094000 usd
CY2022Q1 us-gaap Property Management Fee Revenue
PropertyManagementFeeRevenue
3506000 usd
CY2023Q1 pebk Miscellaneous Income Loss
MiscellaneousIncomeLoss
2161000 usd
CY2022Q1 pebk Miscellaneous Income Loss
MiscellaneousIncomeLoss
1739000 usd
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
3611000 usd
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
7046000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6500000 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5849000 usd
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
2014000 usd
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
1916000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
399000 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
373000 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
189000 usd
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
165000 usd
CY2023Q1 pebk Debit Card Expense
DebitCardExpense
273000 usd
CY2022Q1 pebk Debit Card Expense
DebitCardExpense
276000 usd
CY2023Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
110000 usd
CY2022Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
110000 usd
CY2023Q1 pebk Appraisal Management Fee Expense
AppraisalManagementFeeExpense
1650000 usd
CY2022Q1 pebk Appraisal Management Fee Expense
AppraisalManagementFeeExpense
2772000 usd
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2567000 usd
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1880000 usd
CY2023Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
13702000 usd
CY2022Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
13341000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4023000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4300000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
851000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
848000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3172000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3452000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.34
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.33
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
105195000 usd
CY2023Q1 pebk Adoption Of New Accounting Standard Net Of Tax
AdoptionOfNewAccountingStandardNetOfTax
-838000 usd
CY2023Q1 pebk Cash Dividends Declared On Common Stock
CashDividendsDeclaredOnCommonStock
-1925000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
6000 usd
CY2023Q1 pebk Equity Incentive Plan Net
EquityIncentivePlanNet
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3172000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9173000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
114783000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
142369000 usd
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-199000 usd
CY2022Q1 pebk Cash Dividends Declared On Common Stock
CashDividendsDeclaredOnCommonStock
-1877000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
41000 usd
CY2022Q1 pebk Equity Incentive Plan Net
EquityIncentivePlanNet
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3452000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-18342000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
125444000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3172000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3452000 usd
CY2022Q1 pebk Restricted Stock Expense1
RestrictedStockExpense1
56000 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
700000 usd
CY2023Q1 pebk Proceeds From Fed Funds Purchased
ProceedsFromFedFundsPurchased
43275000 usd
CY2022Q1 pebk Proceeds From Fed Funds Purchased
ProceedsFromFedFundsPurchased
0 usd
CY2023Q1 pebk Repayments Of Fed Funds Purchased
RepaymentsOfFedFundsPurchased
43275000 usd
CY2022Q1 pebk Repayments Of Fed Funds Purchased
RepaymentsOfFedFundsPurchased
0 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
305106000 usd
CY2023Q1 pebk Preferred Securities
PreferredSecurities
20600000 usd
CY2023Q1 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
838000 usd
CY2023Q1 us-gaap Provision For Other Losses
ProvisionForOtherLosses
2300000 usd
CY2023Q1 us-gaap Debt Securities Trading Realized Loss
DebtSecuritiesTradingRealizedLoss
1200000 usd
CY2023Q1 pebk Available For Sale Securities Amortized Costs
AvailableForSaleSecuritiesAmortizedCosts
449031000 usd
CY2023Q1 pebk Available For Sale Securities Gross Unrealized Gain
AvailableForSaleSecuritiesGrossUnrealizedGain
836000 usd
CY2023Q1 pebk Available For Sale Securities Gross Unrealized Losses
AvailableForSaleSecuritiesGrossUnrealizedLosses
50719000 usd
CY2023Q1 pebk Estimated Fair Value
EstimatedFairValue
399148000 usd
CY2022Q4 pebk Available For Sale Securities Amortized Costs
AvailableForSaleSecuritiesAmortizedCosts
507186000 usd
CY2022 pebk Available For Sale Securities Gross Unrealized Gain
AvailableForSaleSecuritiesGrossUnrealizedGain
536000 usd
CY2022 pebk Available For Sale Securities Gross Unrealized Losses
AvailableForSaleSecuritiesGrossUnrealizedLosses
62328000 usd
CY2022 pebk Estimated Fair Value
EstimatedFairValue
445394000 usd
CY2023Q1 pebk Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Values
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValues
85610000 usd
CY2023Q1 pebk Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsLosses
5388000 usd
CY2023Q1 pebk Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Values
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValues
280108000 usd
CY2023Q1 pebk Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerLosses
45330000 usd
CY2023Q1 pebk Available For Sale Securities Continuous Unrealized Loss Position Fair Values
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValues
365718000 usd
CY2023Q1 pebk Available For Sale Securities Continuous Unrealized Loss Position Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLosses
50719000 usd
CY2022Q4 pebk Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Values
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValues
199903000 usd
CY2022 pebk Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsLosses
16697000 usd
CY2022Q4 pebk Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Values
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValues
212326000 usd
CY2022 pebk Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerLosses
45631000 usd
CY2022Q4 pebk Available For Sale Securities Continuous Unrealized Loss Position Fair Values
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValues
412229000 usd
CY2022 pebk Available For Sale Securities Continuous Unrealized Loss Position Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLosses
62328000 usd
CY2023Q1 pebk Unrealized Losses In Investment Securites Portfolio Relating To Debt Securities
UnrealizedLossesInInvestmentSecuritesPortfolioRelatingToDebtSecurities
50700000 usd
CY2022Q4 pebk Unrealized Losses In Investment Securites Portfolio Relating To Debt Securities
UnrealizedLossesInInvestmentSecuritesPortfolioRelatingToDebtSecurities
62300000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2985000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2905000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
13811000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
12663000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
45941000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
39331000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
90270000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
70429000 usd
CY2023Q1 pebk Available For Sale Securities Debt Maturities Mortgage Backed Securities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesMortgageBackedSecuritiesAmortizedCost
296024000 usd
CY2023Q1 pebk Available For Sale Securities Debt Maturities Mortgage Backed Securities Fair Value
AvailableForSaleSecuritiesDebtMaturitiesMortgageBackedSecuritiesFairValue
273820000 usd
CY2023Q1 pebk Available For Sale Securities Amortized Costs
AvailableForSaleSecuritiesAmortizedCosts
449031000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
399148000 usd
CY2023Q1 pebk Proceeds From Sale Of Available For Sale Securities Others
ProceedsFromSaleOfAvailableForSaleSecuritiesOthers
53500000 usd
CY2023Q1 pebk Gains On Sales Of Available For Sale Securities
GainsOnSalesOfAvailableForSaleSecurities
270000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
177000 usd
CY2023Q1 us-gaap Deposit Liabilities Collateral Issued Financial Instruments
DepositLiabilitiesCollateralIssuedFinancialInstruments
99600000 usd
CY2022Q4 us-gaap Deposit Liabilities Collateral Issued Financial Instruments
DepositLiabilitiesCollateralIssuedFinancialInstruments
96000000 usd
CY2022Q1 pebk Loans Ending Balance Individually Evaluated For Impairments
LoansEndingBalanceIndividuallyEvaluatedForImpairments
11783000 usd
CY2022Q1 pebk Loans Ending Balance Collectively Evaluated For Impairments
LoansEndingBalanceCollectivelyEvaluatedForImpairments
877975000 usd
CY2023Q1 pebk Operating Lease Right Of Use Asset1
OperatingLeaseRightOfUseAsset1
4900000 usd
CY2023Q1 pebk Operating Lease Liability1
OperatingLeaseLiability1
5000000.0 usd
CY2023Q1 pebk Loans And Leases Receivable Net Of Deferred Income One
LoansAndLeasesReceivableNetOfDeferredIncomeOne
1050871000 usd
CY2022Q4 pebk Loans And Leases Receivable Net Of Deferred Income One
LoansAndLeasesReceivableNetOfDeferredIncomeOne
1032608000 usd
CY2023Q1 pebk Less Allowance For Loan Losses
LessAllowanceForLoanLosses
9617000 usd
CY2022Q4 pebk Less Allowance For Loan Losses
LessAllowanceForLoanLosses
10494000 usd
CY2023Q1 pebk Loans And Leases Receivable Net Reported Amount1
LoansAndLeasesReceivableNetReportedAmount1
1041254000 usd
CY2022Q4 pebk Loans And Leases Receivable Net Reported Amount1
LoansAndLeasesReceivableNetReportedAmount1
1022114000 usd
CY2023Q1 pebk Financing Receivable Recorded Investment30 To89 Days Past Due36
FinancingReceivableRecordedInvestment30To89DaysPastDue36
6053000 usd
CY2023Q1 pebk Financing Receivable Recorded Investment Loans Ninty Or More Days Past Due
FinancingReceivableRecordedInvestmentLoansNintyOrMoreDaysPastDue
537000 usd
CY2023Q1 pebk Total Past Due Loans
TotalPastDueLoans
6590000 usd
CY2023Q1 pebk Total Current Loans
TotalCurrentLoans
1044281000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1050871000 usd
CY2023Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0 usd
CY2022Q4 pebk Financing Receivable Recorded Investment30 To89 Days Past Due36
FinancingReceivableRecordedInvestment30To89DaysPastDue36
8038000 usd
CY2022Q4 pebk Financing Receivable Recorded Investment Loans Ninty Or More Days Past Due
FinancingReceivableRecordedInvestmentLoansNintyOrMoreDaysPastDue
520000 usd
CY2022Q4 pebk Total Past Due Loans
TotalPastDueLoans
8558000 usd
CY2022Q4 pebk Total Current Loans
TotalCurrentLoans
1024050000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1032608000 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0 usd
CY2023Q1 us-gaap Net Investment In Lease Nonaccrual No Allowance
NetInvestmentInLeaseNonaccrualNoAllowance
3644000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
3644000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
3728000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
686000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
686000 usd
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
16479000 usd
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
657000 usd
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
14720000 usd
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
15377000 usd
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
683000 usd
CY2022Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
17690000 usd
CY2022Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
216000 usd
CY2022 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
16190000 usd
CY2022 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
862000 usd
CY2023Q1 pebk Impaired Loan Amount
ImpairedLoanAmount
5300000 usd
CY2022Q4 pebk Impaired Loan Amount
ImpairedLoanAmount
4900000 usd
CY2023Q1 us-gaap Allowance For Loan And Lease Losses Loans Acquired
AllowanceForLoanAndLeaseLossesLoansAcquired
47000 usd
CY2022 us-gaap Allowance For Loan And Lease Losses Loans Acquired
AllowanceForLoanAndLeaseLossesLoansAcquired
44000 usd
CY2023Q1 pebk Beginning Balance
BeginningBalance
10494000 usd
CY2023Q1 pebk Cecl For Adjustment
CeclForAdjustment
1058000 usd
CY2023Q1 pebk Chargeoffs
Chargeoffs
-166000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
82000 usd
CY2023Q1 pebk Provision Recovery For Unfunded Commitments
ProvisionRecoveryForUnfundedCommitments
-203000 usd
CY2023Q1 pebk Lossesforloan
lossesforloan
427000 usd
CY2023Q1 pebk Ending Balance
EndingBalance
11692000 usd
CY2023Q1 pebk Loss Of Creditlossloans
LossOfCreditlossloans
9617000 usd
CY2023Q1 pebk T Losses For Credit Losses Loan Commitments
tLossesForCreditLossesLoanCommitments
2075000 usd
CY2023Q1 pebk Allowance For Credit Losses
AllowanceForCreditLosses
11692000 usd
CY2022Q1 pebk Beginning Balance
BeginningBalance
9355000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
160000 usd
CY2022Q1 pebk Provision Recovery
ProvisionRecovery
71000 usd
CY2022Q1 pebk Ending Balance
EndingBalance
9426000 usd
CY2022Q1 pebk Allowance For Loan Losses Ending Balance Individually Evaluated For Impairment
AllowanceForLoanLossesEndingBalanceIndividuallyEvaluatedForImpairment
702000 usd
CY2022Q1 pebk Ending Balance Collectively Evaluated For Impairments
EndingBalanceCollectivelyEvaluatedForImpairments
8724000 usd
CY2022Q1 pebk Allowance For Loan Losses Ending Balance
AllowanceForLoanLossesEndingBalance
9426000 usd
CY2022Q1 pebk Loans Ending Balance
LoansEndingBalance
889758000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1032608000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3172000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5475603000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16967000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
163680000 shares
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3172000 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5656250000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3452000 usd
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5497107000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
13159000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
163038000 shares
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3452000 usd
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5673304000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2023Q1 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
417000 usd
CY2023Q1 pebk Individually Evaluated Loans
IndividuallyEvaluatedLoans
0 usd
CY2022Q4 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
211000 usd
CY2022Q4 pebk Impaired Loans
ImpairedLoans
14694000 usd
CY2023Q1 us-gaap Debt Instrument Term
DebtInstrumentTerm
P15Y
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
206000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
189000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
204000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
575000 usd
CY2023Q1 pebk Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
0 usd
CY2022Q1 pebk Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
0 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1759000 usd
CY2023Q1 pebk Weighted Average Remaining Lease Term Operating Leases
WeightedAverageRemainingLeaseTermOperatingLeases
P9Y1M13D
CY2022Q1 pebk Weighted Average Remaining Lease Term Operating Leases
WeightedAverageRemainingLeaseTermOperatingLeases
P8Y11M1D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0260 pure
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0204 pure
CY2023Q1 pebk Operating Leases Future Minimum Payment Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentDueInRollingYearTwo
605000 usd
CY2023Q1 pebk Operating Leases Future Minimum Payment Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentDueInRollingYearThree
750000 usd
CY2023Q1 pebk Operating Leases Future Minimum Payment Due In Rolling Year Four
OperatingLeasesFutureMinimumPaymentDueInRollingYearFour
694000 usd
CY2023Q1 pebk Operating Leases Future Minimum Payment Due In Rolling Year Five
OperatingLeasesFutureMinimumPaymentDueInRollingYearFive
577000 usd
CY2023Q1 pebk Operating Leases Future Minimum Payment Next Rolling Twelve Months
OperatingLeasesFutureMinimumPaymentNextRollingTwelveMonths
536000 usd
CY2023Q1 pebk Operating Leases Future Minimum Payment Due In Rolling After Year Five
OperatingLeasesFutureMinimumPaymentDueInRollingAfterYearFive
2580000 usd
CY2023Q1 pebk Operating Leases Future Minimum Payment Due
OperatingLeasesFutureMinimumPaymentDue
5742000 usd
CY2023Q1 us-gaap Receivables With Imputed Interest Amortization Amount
ReceivablesWithImputedInterestAmortizationAmount
709000 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
5033000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001654954-23-005964-index-headers.html Edgar Link pending
0001654954-23-005964-index.html Edgar Link pending
0001654954-23-005964.txt Edgar Link pending
0001654954-23-005964-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pebk-20230331.xsd Edgar Link pending
pebk_10q.htm Edgar Link pending
pebk_ex31a.htm Edgar Link pending
pebk_ex31b.htm Edgar Link pending
pebk_ex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
pebk-20230331_def.xml Edgar Link unprocessable
pebk-20230331_cal.xml Edgar Link unprocessable
pebk-20230331_lab.xml Edgar Link unprocessable
pebk-20230331_pre.xml Edgar Link unprocessable
pebk_10q_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending